MedPath

Ignis Therapeutics (HK) Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

PPB:11

Drug Approvals

SUNOSI TABLETS 150MG

Approval Date
Oct 11, 2024
PPB

SUNOSI TABLETS 75MG

Approval Date
Oct 11, 2024
PPB

XCOPRI TABLETS 50MG

Approval Date
Feb 28, 2023
PPB

XCOPRI TABLETS 50MG AND 100MG (TITRATION PACK)

Approval Date
Feb 28, 2023
PPB

XCOPRI TABLETS 100MG

Approval Date
Feb 28, 2023
PPB

XCOPRI TABLETS 150MG AND 200MG (350MG DAILY DOSE MAINTENANCE PACK)

Approval Date
Feb 28, 2023
PPB

XCOPRI TABLETS 200MG

Approval Date
Feb 28, 2023
PPB

XCOPRI TABLETS 12.5MG AND 25MG (TITRATION PACK)

Approval Date
Feb 28, 2023
PPB

XCOPRI TABLETS 150MG AND 200MG (TITRATION PACK)

Approval Date
Feb 28, 2023
PPB

XCOPRI TABLETS 100MG AND 150MG (250MG DAILY DOSE MAINTENANCE PACK)

Approval Date
Feb 28, 2023
PPB
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.